OXADIAZOLINE LIGANDS FOR MODULATING THE EXPRESSION OF EXOGENOUS GENES VIA AN ECDYSONE RECEPTOR COMPLEX

Patent №

US 8,669,072

Granted

2014-03-11

Filed 2007

Owner

Lab

AI components

1

hardware

Assignment

None on record

Dataset

AIPD

2023_r1 edition

Application

11838090

The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system, and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene.

AI hardwareC07D 271/06A61P 35/00A61P 43/00C07D 413/12

AI classification

AI hardware0.98
Natural language0.00
Vision0.00
Speech0.00
Machine learning0.00
Evolutionary computation0.00
Knowledge representation0.00
Planning0.00
© 2026 NYSGPT2525 LLC